Robert Ghenchev News Today

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulation...

DocuSign Envelope ID: 6C6CA0B7-8C73-439A-9C0D-FB4F60A7ED94 Company No. 3252665 Oxford Biomedica plc (the "Company") Minutes of the Annual Gen...

Investegate announcements from Oxford Biomedica PLC, Result of AGM

Investegate announcements from Oxford Biomedica PLC, 2021 Annual report and accounts & AGM notification

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

  London, UK - 27 April 2021: Oxford Biomedica plc ("Oxford Biomedica", "the Company" or "the Group") (LSE:OXB), a leading gene and cell therapy group, gives notice that copies of the 2020 Annual report and accounts and the Notice of Annual General Meeting ("AGM") have been sent to shareholders. These documents are available on the "Investors" section of the Groups website at www.oxb.com . Oxford Biomedica plc announced its preliminary results for the year end...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Mission Bio Announces Yan Zhang as New CEO April 8, 2021 GMT SAN FRANCISCO, April 8, 2021 /PRNewswire/ -- Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced the appointment of Yan Zhang to the role of CEO. Zhang joins Mission Bio after 10 years at Thermo Fisher Scientific, where she drove above-market growth for multiple business lines, including leading...